Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes
Authors
Liudmyla G. Savchenko
Department of Internal Medicine No.3 with Phthisiology, Ukrainian Medical Stomatological Academy, Poltava, Ukraine
Nataliia I. Digtiar
Department of Internal Medicine No.3 with Phthisiology, Ukrainian Medical Stomatological Academy, Poltava, Ukraine
Liudmyla G. Selikhova
Department of Internal Medicine No.3 with Phthisiology, Ukrainian Medical Stomatological Academy, Poltava, Ukraine
Elvira I. Kaidasheva
Endocrinology Department, City Clinical Hospital No. 2, Poltava, Ukraine
Oksana A. Shlykova
Research Institute for Genetics and Immunological Grounds of Pathology and Pharmacogenetics, Ukrainian Medical Stomatological Academy, Poltava, Ukraine
Liudmyla E. Vesnina
Research Institute for Genetics and Immunological Grounds of Pathology and Pharmacogenetics, Ukrainian Medical Stomatological Academy, Poltava, Ukraine
Igor P. Kaidashev
Department of Internal Medicine No.3 with Phthisiology, Ukrainian Medical Stomatological Academy, Poltava, Ukraine
Language: English
Page range: 233 - 240
Submitted on: Sep 26, 2018
Published on: Sep 9, 2019
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2019 Liudmyla G. Savchenko, Nataliia I. Digtiar, Liudmyla G. Selikhova, Elvira I. Kaidasheva, Oksana A. Shlykova, Liudmyla E. Vesnina, Igor P. Kaidashev, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.